PEF treatment registry for follow-up care
Part of Skin clinical trials.
This study collects information about people who receive a type of device-based electrical treatment (PEF) using Galvanize technology. It helps researchers understand outcomes after treatment by tracking follow-up data during routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having—or already had—PEF treatment using the Galvanize device
- Your doctor expects to be able to follow up with you using their usual care plan
- If enrolling ahead of time: you are expected to live at least 3 months
- If enrolling after treatment: you have had at least 3 months of follow-up imaging
- You agree to participate (sign consent if your hospital requires it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called pulsed electric field (PEF) therapy for people with advanced or unresectable esophageal squamous cell carcinoma. PEF uses short electrical pulses to target and destroy cancer cells. This study is for patients who cannot have surgery or standard treatments, and looks at how safe and effective this therapy is.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial tests a new way to treat breast cancer that has spread to the skin or just under the skin. It uses short electric pulses to target tumors without cutting. The goal is to see if this approach can safely destroy cancer cells in those spots.
This trial is a registry that tracks patients who have had a second pulsed-field ablation (PFA) procedure for atrial fibrillation after a first PFA treatment. The goal is to learn more about how safe and effective these repeat procedures are.
This trial tests a new treatment called pulsed electric field therapy for people with advanced lung cancer (stage III or IV) that has not responded to first-line immunotherapy. It uses targeted electrical pulses to destroy tumor cells, and may be an option for those who still have other measurable tumors.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
Hear when a new Soft Tissue Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.